The risk of venous thromboembolism in non-large-joint surgeries

Orthopedics

Volumn 26, Issue 2 SUPPL., 2003, Pages

  Muntz, James E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CERTOPARIN; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; WARFARIN;

ARTHROSCOPIC SURGERY; ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; HIGH RISK PATIENT; HUMAN; JOINT SURGERY; KNEE ARTHROSCOPY; LEG FRACTURE; LUNG EMBOLISM; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

ARTHROPLASTY, REPLACEMENT, KNEE; ARTHROSCOPY; DRUG ADMINISTRATION SCHEDULE; FEMORAL FRACTURES; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; TIBIAL FRACTURES; VENOUS THROMBOSIS;

EID: 0037321076     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Janku GV, Paiement G, Green HD. Prevention of thromboembolism in orthopaedics in the United States. Clin Orthop. 1996;325:313-321.
2. Demers C, Marcoux S, Ginsberg JS, Laroche F, Cloutier R, Poulin J. Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med. 1998; 158:47-50.
3. Caprini JA, Motykie GD, Arcelus JI, Kudrna JC, Cella DF, Reyna JJ. Investigating the prevalence and pathophysiology of the post-thrombotic syndrome after total hip arthroplasty [abstract]. Int Angiol. 2000; 19:382-383.
4. Edelsberg J, Ollendorf D, Oster G. Venous thromboembolism following major orthopedic surgery: review of epidemiology and economics. Am J Health Syst Pharm. 2001; 58:4-13.
5. Nerurkar J, Wade WE, Martin BC. Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty. Pharmacotherapy. 2002; 22:990-1000.
6. Wirth T, Schneider B, Misselwitz F, et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin: results of a randomized controlled trial. Arthroscopy. 2001; 17:393-399.
7. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega A. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991; 17:304-312.
8. Williams JS, Hulstyn MJ, Fadale PD, et al. Incidence of deep vein thrombosis after arthroscopic knee surgery: a prospective study. Arthroscopy. 1995; 11:701-705.
9. Durica S, Raskob G, Johnson C, et al. Incidence of deep-vein thrombosis after arthroscopic knee surgery. Thromb Haemost. 1997; 79:183.
10. Schippinger G, Wirnsberger GH, Obernosterer A, Babinski K. Thromboembolic complications after arthroscopic knee surgery. Incidence and risk factors in 101 patients. Acta Orthop Scand. 1998; 69:144-146.
11. Jaureguito JW, Greenwald AE, Wilcox JF, Paulos LE, Rosenberg TD. The incidence of deep vein thrombosis after arthroscopic knee surgery. Am J Sports Med. 1999; 27:707-710.
12. Holland K, Schain FH. Thromboseprophylaxe mit Fraxiparin 0,3 nach arthroskopischen Eingriffen. Fortschr Med. 1995; 113:335-336.
13. Hjelmstedt A, Bergvall U. Incidence of thrombosis in patients with tibial fractures. Acta Chir Scand. 1968; 134:209-218.
14. Abelseth G, Buckley RE, Pineo GE, Hull R, Rose MS. Incidence of deep-vein thrombosis in patients with fractures of the lower extremity distal to the hip. J Orthop Trauma. 1996; 10:230-235.
15. Wang F, Wera G, Knoblich GO, Chou LB. Pulmonary embolism following operative treatment of ankle fractures: a report of three cases and review of the literature. Foot Ankle Int. 2002; 23:406-410.
16. Mizel MS, Temple HT, Michelson JD, et al. Thromboembolism after foot and ankle surgery. A multicenter study. Clin Orthop. 1998; 348: 180-185.
17. Spannagel U, Kujath P. Low-molecular-weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster cast. Semin Thromb Hemost. 1993; 19:131-141.
18. Kock HJ, Schmit-Neuerburg KP, Hanke J, Rudofsky G, Hirche H. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet. 1995; 346:459-461.
19. Lassen MR, Borris LC, Nakov RL. Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med. 2002; 347:726-730.